Latest News:
Regenerating human skeletal muscle forms an emerging niche in vivo to support PAX7 cells
Read More
Research
Affiliations
In the News
Publications
About Us
Join the Team
Contact Us
March 16, 2021
A single CRISPR-Cas9 deletion strategy that targets the majority of DMD patients restores dystrophin function in hiPSC-derived muscle cells
Previous Post
Next Post